SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out...
NOV 15.67+0.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kelvin Taylor who wrote (297)6/16/1998 12:50:00 AM
From: Todd D. Wiener  Read Replies (1) of 420
 
Kelvin-

I think that NOV is attractive right now. Unfortunately, the rebound from $10.50 was only a correction in a downtrend, and NOV will probably revisit $10.50 or so, where it will put in a bottom (hopefully). According to the company, the fundamentals are good, so I continue to believe that the stock is undervalued. It's difficult to keep the faith sometimes, especially during market (and stock) corrections. But as long as the fundamentals for a particular stock remain positive, the best way to handle it is either to ignore the price fluctuations or take advantage of the low prices.

I'm doing the latter, although not on NOV this time. I have recently lengthened my position in THQI at $21 and SMTC at $17. I plan to buy more NCES at slightly lower prices, too.

NOV is technically weak-neutral right now. Any purchases should be made due to a positive fundamental picture, not technical.

Good luck,

Todd
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext